HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Primary Immune Thrombocytopenia
October 29, 2026
manilatimes.net
Biel Crystal Holdings did not disclose further details of the IPO in its filing to the city's stock exchange on Friday, although various reports say the company is planning to raise about $2 billion.
